戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 F (-0.821) > AOCS (-0.798) > AOAC (-0.795) > BIS (-0.754).
2       In this work, anticancer properties of bis (1,10-phenanthroline) silver (I) acetate monohydrate
3                The P2X(7) antagonists 1-[N,O-bis (1,5-isoquinolinesulfonyl)-N-methyl-l-tyrosyl]-4-pip
4 of a ditopic ligand, which consists of a 2,6-bis-(1'-methylbenzimidazolyl)-4-oxypyridine moiety attac
5 arbonylbis(imino-3,1-phenylenecarbonylamino)]bis-(1,3,5-naphthalen etrisulfonic acid), 6Na (NF023), 8
6 measured using the dyes propidium iodide and bis-(1,3-dibutylbarbituric acid) trimethine oxonol to de
7  is indicated by the potential-sensitive dye bis-(1,3-dibutylbarbituric acid)pentamethine oxonol.
8 tential using the slow voltage-sensitive dye bis-(1,3-diethylthiobarbituric acid)trimethine oxonol re
9  the distance of the binding site for diTBA (bis-(1,3-diethylthiobarbituric acid)trimethine oxonol),
10 f the first members of a new family of spiro-bis-(1,9-diamino-substituted-phenalenyl)boron neutral ra
11 quadruplex targeting fluorophore (BMVC, 3, 6-bis-(1-methyl-4-vinylpyridinium)-carbazole diiodide) and
12 or glasses prepared from indomethacin or 1,3-bis-(1-naphthyl)-5-(2-naphthyl)benzene, stability is opt
13 *2H2O 4, CMCR.2bpeh*benzil*ethanol 5 (bpeh = bis-(1-pyridin-4-yl-ethylidene)-hydrazine), and CECR*2bp
14 t in self-assembled films of the derivative, bis-[1-(10-decyl)-4-[2-(4-dimethylaminonaphthalen-1-yl)-
15             Moreover, topical application of Bis (100 microM) once daily for 9 d to the freshly depil
16 ed by plasmid DNA and the redox-active lipid bis-(11-ferrocenylundecyl)dimethylammonium bromide (BFDM
17 e mono-(13)C ((13)C identical with(12)C) and bis-(13)C ((13)C identical with(13)C) labeled alkyne iso
18 determine 18O/16O ratios for 5',3'-guanosine bis-[18O1]phosphate and TM[18O1]P with precisions of app
19 '-ethynyl-(2,2';6',2''-terpyridinyl))-10,2 0-bis (2',6'-bis(3,3-dimethyl-1-butyloxy)phenyl)porphinato
20 yl) ether [BADGE.HCl.H(2)O], and bisphenol A bis (2,3-dihydroxypropyl) ether [BADGE.2H(2)O], using hi
21 lhexyl 2,3,4,5-tretabromophalate (TBPH), 1,2-bis (2,4,6-tribromophenoxy) ethane (BTBPE), and decabrom
22 preincubated with acetoxymethyl ester of 1,2-bis (2-amino-phenoxy) ethane N:, N:, N:, N:-tetra-acetic
23 PK inhibitors 1, 4-diamino-2, 3-dicyano-1, 4-bis (2-aminophenylthio) butadiene (UO126; for ERK1/2), t
24  fluorescent pH indicator (pyranin or [2',7'-bis (2-carboxyethyl)-5(6)-carboxyfluorescein] [BCECF]) w
25 ed greater resistance to cell killing by 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) than overexpres
26  1-chloro, 2,4-dinitrobenzene (CDNB); or 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU).
27           The fraction of naturally produced bis (2-ethylhexyl) phthalate (DEHP), a ubiquitous plasti
28 lyzed for the presence of bisphenol A (BPA), bis (2-ethylhexyl) phthalate (DEHP), nonylphenol monoeth
29 c monoketone analog of curcumin, termed 3, 5-bis (2-flurobenzylidene) piperidin-4-one (EF24), has bee
30 ors were immersed in pH indicator or glyoxal bis (2-hydro-xyanil) (GBHA).
31               Systemically administered N,N'-bis (2-hydroxybenzyl) ethylenediamine-N,N'-diacetic acid
32 i-beta-glucan monoclonal antibody, using 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) c
33 s and Candida parapsilosis by using XTT [2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) c
34 queous and dried coffee rings of 5-5'-Dithio-bis (2-nitrobenzoic acid) (DTNB) solutions were examined
35 bation of BLMVECs with the GR inhibitor, 1,3 bis-(2 chloroethyl)-1-nitrosourea, abolished the inhibit
36 minal positions with acrylodan and ruthenium bis-(2,2'-bipyridyl)-1,10-phenanthroline-9-isothiocyanat
37 s three large slowly reversible antagonists, bis-(2,2,6,6-tetramethyl-4-piperidinyl) sebacate (BTMPS)
38 sed free N-heterocyclic carbenes (NHCs), 1,3-bis-(2,4,6-trimethylphenyl)imidazol-2-ylidene (IMes) and
39  are contrasted with the case of the related bis-(2,5-di-tert-butylphenyl)perylenetetracarboxylic dii
40                                  Reaction of bis-(2,6-diisopropylphenyl)-imidazol-2-ylidene borane wi
41 thylphenyl)imidazol-2-ylidene (IMes) and 1,3-bis-(2,6-diisopropylphenyl)imidazol-2-ylidene (IPr), and
42        Treatment with an agonist of CAR, 1,4-bis-(2-(3,5-dichloropyridoxyl))benzene, potentiated CAR-
43 ting agents cyclopiazonic acid (CPA) and 1,2-bis-(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (B
44                                          1,2-Bis-(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-ac
45 c initiator (R)- or (S)-1,1'-binaphthyl-2,2'-bis-(2-bromoisobutyrate).
46 eno[3,4-b]thiophenyl]-2,2'-dicarboxylic acid bis-(2-butyloctyl) ester (BTT) and 4,8-bis(2-butyloctyl)
47 one of the following: acetoxymethyl of 2',7'-bis-(2-carboxyethyl)-5-(and 6)-carboxyfluorescein (BCECF
48 related with a rise in pH indicated by 2',7'-Bis-(2-Carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF
49                The fluorophore used is 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF
50 using the pH-sensitive fluorescent dye 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF
51 ed by the pH-sensitive fluorescent dye 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF
52 tive cantilever biosensor and a probe, 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein acetox
53                The chemical pH-indicator 2,7-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein corrob
54  by using the cytoplasmic pH indicator 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein-acetox
55  with intrabacterial pH measured using 2',7'-bis-(2-carboxyethyl)-5-carboxyfluorescein and compared t
56 EK) on exposure to the DNA-damaging compound bis-(2-chloroethyl) sulfide.
57  Additional cycles of chemotherapy using 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) resulted in sim
58  furthermore applied to the reaction of N,N'-bis-(2-cyanothiocarbonyl)pyrazine 1h with sulfonyl azide
59                                              Bis-(2-ethylhexyl) tetrabromophthalate (TBPH) is widely
60                                    Poly[{2,5-bis-(2-ethylhexyl)-3,6-bis-(thien-2-yl)-pyrrolo[3,4-c]py
61 ndgap donor-acceptor copolymer poly[2,6-(4,4-bis-(2-ethylhexyl)-4H-cyclopenta[2,1-b;3,4-b']-dithiophe
62 DP was detected from 0.26 to 11 pg m(-3) and bis-(2-ethylhexyl)-tetrabromophthalate (TBPH) ranged fro
63                                      2-[(2-[[Bis-(2-ethylsulfanylethyl)amine]methyl]phenylamine)methy
64                                  2-[11-[(2-[[Bis-(2-ethylsulfanylethyl)amino]methyl]phenylamino)methy
65                                          1,3-Bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) i
66 mino]-nicotinic acid [PD307243 (PD)] and 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea [NS1643 (N
67   The crystal and molecular structure of the bis-(2-MeImH) complex shows the macrocycle to be in a sa
68 ent of the eight methylene resonances of the bis-(2-MeImH) complex to the four ethyl groups was possi
69 R spectrum of this complex, like that of the bis-(2-MeImH) complex, is of the "large g(max)" type, wi
70  A as compared to 1.974 A) than those of the bis-(2-MeImH) complex.
71 anthroline (CuP) or the bifunctional reagent bis-(2-methanethiosulfonatoethyl)amine hydrochloride (bi
72 s blocked by the oxidizing agent 5,5'-dithio-bis-(2-nitrobenzoic acid) (DTNB) and the T channel antag
73                    A continuous, 5,5'-dithio-bis-(2-nitrobenzoic acid) (DTNB)-based assay for the CBS
74  sulfite value by standard DTNB (5,5'-dithio-bis-(2-nitrobenzoic acid)) method and the present method
75 2] (1) and [(TPA)Fe(OTf)2] (2) [BPMEN = N,N'-bis-(2-pyridylmethyl)-N,N'-dimethyl-1,2-ethylenediamine;
76 itogens phenobarbital (PB) and TCPOBOP (1, 4-bis [2-(3, 5-dichloropyridyloxy)] benzene).
77                                 TCBOPOP (1,4-bis [2-(3,5-dichaloropyridyloxy)] benzene) an agonist of
78                                 TCPOBOP (1,4-Bis [2-(3,5-Dichloropyridyloxy)] benzene) is a constitut
79 ED-CC and TATE-PEG2-HBED-CC (HBED-CC is N,N'-bis [2-hydroxy-5(carboxyethyl)benzyl] ethylenediamine-N,
80 ate-specific membrane antigen)-HBED-CC (N,N'-bis [2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,
81 nthesis and conformational properties of 2,6-bis-[2-((4S)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl)phenyl
82 -N-4-(1-azi-2,2,2-trifluoroethyl)benzoyl-1,3-bis-[2-(3)H] (D-mannose-4-yloxy)-2-propylamine exofacial
83                    Long-term exposure to 1,4-Bis-[2-(3,5-dichloropyridyloxy)] benzene yielded profoun
84  effect on the response to the xenobiotic1,4-Bis-[2-(3,5-dichloropyridyloxy)] benzene.
85 xposed to the mouse-specific CAR ligand, 1,4-bis-[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP).
86 tor (CAR) ligands phenobarbital (PB) and 1,4-bis-[2-(3,5-dichloropyridyloxy)]benzene, and of acetamin
87                            (68)Ga-PSMA-(N,N'-bis-[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,
88              Most notable was NSC 95397 (2,3-bis-[2-hydroxyethylsulfanyl]-[1,4]naphthoquinone), which
89 crine and the bis-pyridinium derivative 4,4'-bis-[(2,6-dichloro-benzyloxy-imino)-methyl]-1,1'-propane
90            With 4-methyl-cis-2-pentene, both bis- (22) and monoadduct (23) were isolated, the former
91                             These are called bis- (3, 6, 9, 12) and monoadducts (4, 7, 10, 13).
92 yl (DPPH) (8.90 mumol TEAC/g) and 2,2'-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) (16.
93 henyl-2-picrylhydrazyl (DPPH) and 2,2'-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium
94 2,2-diphenyl-1-picrylhydrazyl and 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic) acid assays show
95    Trp-Pro was shown to have high 2,2'-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) radical scav
96 ,5,5'-tetramethylbenzidine (TMB), 2,2'-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid), dopamine, a
97 ), P3HT, and the liquid-crystalline poly(2,5-bis (3-tetradecylthiophen-2-yl)thieno[3,2-b]thiophene),
98 olecular-scale packing structure of poly(2,5-bis (3-tetradecylthiophene-2-yl)thieno[3,2-b]thiophene)
99                                              Bis-(3',5') cyclic di-guanylate (c-di-GMP) is a key bact
100 formation in vitro and pathogenesis in vivo--bis-(3',5')-cyclic dimeric GMP (c-di-GMP), flagella, and
101              High cellular concentrations of bis-(3',5')-cyclic dimeric guanosine mono-phosphate (c-d
102 dentified as an inner membrane protein whose bis-(3',5')-cyclic dimeric guanosine monophosphate (c-di
103 colony morphogenesis by modulating levels of bis-(3',5')-cyclic-dimeric-guanosine (c-di-GMP), a secon
104                                              Bis-(3',5')-cyclic-dimeric-guanosine monophosphate (c-di
105 c binding protein NspS and the transmembrane bis-(3'-5') cyclic diguanosine monophosphate (c-di-GMP)
106 ity to form and degrade the second messenger bis-(3'-5') cyclic dimeric GMP (c-di-GMP).
107                                    Bacterial bis-(3'-5') cyclic GMP (cyclic di-GMP [c-di-GMP]) serves
108  pertussis, synthesizes the second messenger bis-(3'-5')-cyclic diguanosine monophosphate (c-di-GMP)
109 nd releases high levels of the STING agonist bis-(3'-5')-cyclic dimeric adenosine monophosphate (c-di
110                               Alterations in bis-(3'-5')-cyclic dimeric GMP (c-di-GMP) levels have be
111 e of cellular levels of the second messenger bis-(3'-5')-cyclic dimeric GMP (c-di-GMP) was identified
112 regulated receptor for the second messenger--bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di
113                         The second messenger bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di
114                                              Bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di
115 acterial second messenger signaling molecule bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di
116                                          The bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di
117               The bacterial second messenger bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di
118  FimX has phosphodiesterase activity towards bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di
119 centration of the bacterial second messenger bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di
120                                              Bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di
121  intracellular secondary messenger c-di-GMP (Bis-(3'-5')-cyclic dimeric guanosine monophosphate), to
122 rts suggested the bacterial second messenger bis-(3'-5')-cyclic-dimeric-guanosine monophosphate (c-di
123                                          1,1-Bis-(3'-indolyl)-1-(p-substitutedphenyl)methanes contain
124 gap polymer (bandgap <1.4 eV), poly[2,7-(5,5-bis-(3,7-dimethyloctyl)-5H-dithieno[3,2-b:2',3'-d]pyran)
125 picrylhydrazyl radical (DPPH) and 2,2'-azino-bis-(3-ethylbenzo-thiazoline-6-sulfonic acid) diammonium
126 ion to scavenge both the cationic 2,2'-azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS(+)) r
127  laccase-catalyzed reaction using 2, 2-Azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) as a
128 3 at pH 2.5 and 70 degrees C with 2,2'-azino-bis-(3-ethylbenzthiazoline-6-sulfonic acid) used as a su
129 isease (AD), we have synthesized 1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (5, BSB).
130 luorescent probe (trans, trans),-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB) tha
131 ing the binding of [(125)I]E,E-6, 1-iodo-2,5-bis-(3-hydroxycarbonyl-4-methoxy)styrylbenzene (IMSB) to
132                           Treatment with 2,6-Bis-(3-methoxy-4-propoxy-benzylidene)-cyclohexanone (BM2
133 r post-ischemia treatment with 40 mg/kg of N-bis-(3-phenyl-propyl)9-oxo-fluorene-2,7-diamide, a novel
134                   Compared to vehicle alone, Bis (300 microM), applied twice daily to paired sites fo
135 e) and the ERbeta selective agonist DPN (2,3-bis (4-hydroxyphenyl) propionitrile) alone and in combin
136  synthesized by solvothermal reaction of 1,4-bis-(4-(3,5-dicyano-2,6-dipyridyl)dihydropyridyl)benzene
137 nalysis shows that SOF-7 comprises 2 and 1,4-bis-(4-(3,5-dicyano-2,6-dipyridyl)pyridyl)benzene (3); t
138 groups as donor connected to a fluorene, 2,7-bis-(4-(N,N-diphenylamino)phen-1-yl)-9,9'-dimethylfluore
139 ylfluorene (1), or spirobifluorene core, 2,7-bis-(4-(N,N-diphenylamino)phen-1-yl)-9,9'-spirobifluoren
140  carries the fluorescent diamidine DB99 (2,5-bis-(4-amidinophenyl)-3,4-dimethylfuran) into trypanosom
141 g the eight chalcone derivatives tested, 3,5-bis-(4-boronic acid-benzylidene)-1-methyl-piperidin-4-on
142 emical series exemplified by N-[5-(1-{3-[2,2-bis-(4-fluoro-phenyl)-acetylamino]-propyl}-piperidin-4-y
143 a HIF-1alpha knockout cell line and 3-[2-[4-(bis-(4-fluorophenyl) methylene]-1-piperidinyl)ethyl]-2,3
144 diphenylmethyl]-1H-pyrazole), senicapoc (2,2-bis-(4-fluorophenyl)-2-phenylacetamide), and NS6180 (4-[
145  and E isomers of the lithium enolate of 1,3-bis-(4-fluorophenyl)-2-propanone (5F-Li) show divergent
146 inistering dopamine reuptake inhibitor 1-(2-[bis-(4-fluorophenyl)methoxy]ethyl)- 4-(3-phenylpropyl)pi
147                     Within the series, 3-[2-[bis-(4-fluorophenyl)methoxy]ethylidene]-8-methyl-8-azabi
148 ium channel blocker, LY393615 ((N-Butyl-[5,5-bis-(4-fluorophenyl)tetrahydrofuran-2-yl]methylamine hyd
149                                Curcumin, 1,7-bis-(4-hydroxy-3-methoxy-phenyl)-hepta-1,6-diene-3,5-dio
150 ovides evidence that the ERbeta agonist, 2,3-bis-(4-hydroxy-phenyl)-propionitrile (DPN), and the sele
151 hyperpolarizable chromophores, based on N,N- bis-(4-methoxyphenyl) aryl-amino donors and phenyl-trifl
152 with organic fluors (diphenyloxazole and 1,4-bis-(4-methyl-5-phenyl-2-oxazolyl)benzene) and an extrac
153   The crystal and molecular structure of the bis-(4-NMe(2)Py) complex also shows the macrocycle to be
154 MS) cleavable cross-linker (containing a 1,3-bis-(4-oxo-butyl)-urea group, BuUrBu) generating charact
155  phenanthrene derivatives, 3,6-diphenyl-9,10-bis-(4-tert-butylphenyl)phenanthrene (TphP, T1), 3,6-di(
156 aphenylporphinato]zinc(II))-6-[(5"-10'',20''-bis [4-(3-methoxy-3-methylbutoxy)phenyl]porphinato)zinc(
157                      Here, we report a novel bis-[4Fe-4S] cluster binding protein, DSD-Fdm, in which
158 loped a novel c-Myc-targeting compound, N, N-bis (5-ethyl-2-hydroxybenzyl) methylamine (EMD), and pre
159  examined the effect of a new compound, N, N-bis (5-ethyl-2-hydroxybenzyl) methylamine (EMD), in targ
160 rt inhibitor 100microM 2,2'-(1,2-ethenediyl) bis (5-isothiocyanatobenzenesulfonic acid).
161 an, 3.17 muM for triclocarban, 0.372 muM for bis-(5-chloro-2-hydroxyphenyl)methane, 4.89 muM for 2-ch
162                        The conversion of 1,3-bis-(6-amino-pyridin-2-yl)-urea (1) with N,N'-carbonyldi
163                                 A library of bis-(6-chloro-2-methoxy-acridin-9-yl) and bis-(7-chloro-
164 -propyl]-piperazin-1-yl]-propyl)-amine, N,N'-bis-(6-chloro-2-methoxy-acridin-9-yl)-1,8-diamino-3,6-di
165 Ni]ClO4.CH3OH (1, bppppa- = monoanion of N,N-bis-[(6-phenyl-2-pyridyl)methyl]-N-[(6-pivaloylamido-2-p
166 d bis-phenyl-C61 -butyric acid methyl ester (bis-[60]PCBM) isomer mixture by preparative peak-recycli
167 of bis-(6-chloro-2-methoxy-acridin-9-yl) and bis-(7-chloro-2-methoxy-benzo[b][1,5]naphthyridin-10-yl)
168 ycles using the p-channel semiconductor 5,5'-bis-(7-dodecyl-9H-fluoren-2-yl)-2,2'-bithiophene (DDFTTF
169 on (NLF) contains the pentapeptide mimic 1,4-Bis (9-O dihydroquinidinyl) phthalazine/hydroquinidine 1
170 structure for the complex of the bisacridine bis-(9-aminooctyl(2-(dimethylaminoethyl)acridine-4-carbo
171 ',6'-diyl)bis(iminomethylene-2 ,1-phenylene)]bis-(9CI), a rhodamine-derived bisboronic acid (RhoBo) d
172                          In this study, N,N'-bis (acetyl acetone) ethylenediimine (Fe3O4@SiO2-EDN) wa
173                   Association constants of a bis-(acetylguanidinium)ferrocene dication to various (di
174 th phthalate and maleate carboxylates to the bis-(acetylguanidinium)ferrocene salt in pure water.
175 posed of NIPAm, degradable crosslinker N, N'-bis (acryloyl) cystamine (BAC), sulfated 2-acrylamido-2-
176                                 The tethered bis-(alkynylcarbene) complex Cp(CO)(2)Re=C(Tol)C(triple
177 orward practical synthetic approaches to 3,4-bis- and 3,4,5-tris(trifluoromethyl)pyrazoles have been
178 anols 15 and 16and their transformation into bis- and mixed-onium chlorofumarates 19, 20ab, and 26.
179                            Comparison of the bis- and monoacridine spermine motifs (8 and 17) reveale
180                                      In both bis- and monoadducts of acyclic alkenes, the configurati
181                                              Bis- and monoadducts were obtained also in additions of
182 ion followed by global deprotection afforded bis- and monophosphorylated hexaacylated Lipid A mimetic
183 rategy for the oDMS structures by which both bis- and monosubstituted oDMS derivatives up to 59 Si-at
184                                        Novel bis- and tetraepoxides and bicyclic acetal products, ari
185 ion dictates the formation of uranium mono-, bis- and tris(imido) products.
186 howed excellent activity in the synthesis of bis- and tris-1,4-substituted 1,2,3-triazoles.
187 tive polyborylation was also shown providing bis- and tris-borylated phosphines.
188 so indicate that the triaroylbenzene-derived bis- and tris-crown ethers do not engage in intramolecul
189 s for convergent synthesis of highly complex bis- and tris-diazene intermediates.
190 oether conjugates parallels the formation of bis- and tris-glutathionyl conjugates of hydroquinone, w
191                                Additionally, bis- and tris-homoallylic alcohols are oxidized to provi
192 ansfer can give either mono- or bis-NHCs, or bis- and tris-NHCs.
193 y conventional or microwave heating and that bis- and tris-primary alcohols are also processed effici
194 um energy equilibrium geometries of explicit bis- and tris-solvated contact ion pairs (CIPs) and tetr
195 luated using three selected series of mono-, bis-, and tris-adducted fullerene materials.
196 (ESR) measurements measurements of pristine, bis-, and tris-adducts of Gd(3)N@C(80) suggested that th
197 y (BP86) calculations of 1syn and its mono-, bis-, and tris-Ag(I) complexes suggested that the coordi
198 S-CC-MgBr) leads to a distribution of mono-, bis-, and tris-alkynylated iron(II)-SciOPP species due t
199 ipyridyl)dihydropyridyl)benzene (1) and 5,5'-bis-(azanediyl)-oxalyl-diisophthalic acid (2).
200 containing a cleavable disulfide; (2) 2',2''-bis-(AzC12)-CL with two of the four fatty acid tails of
201 from a monomer unit, which consists of a 2,6-bis-(benzimidazolyl)-4-hydroxypyridine unit attached to
202  Ca(2+) and calcium chelator ethylene glycol-bis (beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (
203  Many biological systems use ethylene glycol bis (beta-aminoethylether)-N,N,N',N'-tetraacetic acid (E
204      Trifluoperazine, W7, or ethylene glycol-bis-(beta-aminoethyl ether)-N,N'-tetraacetic acid (EGTA)
205 ments, the effect of calcium, ethyleneglycol-bis-(beta-aminoethyl ether)-N-N' -tetraacetic acid (EGTA
206 ion of the calcium chelator, ethylene-glycol-bis-(beta-aminoethylether)-N,N,N',N'-tetraacetic acid, g
207 tly treated with 1 millimolar ethyleneglycol-bis-[beta-aminoethylether]-N,N,N',N'-tetraacetic acid [E
208 S)-N,N'-bis-(phenylsulfonyl)-, and (2S)-N,N'-bis-(Boc)-3-(2-pyrrolyl)alanines (10, 3, and 14, respect
209 se whose activity is restricted to tris- and bis-, but not mono-phosphorylated phosphatidylinositol p
210 ,4'''-[carbonyl-bis[imino-5,1,3-benzenetriyl-bis-(carbonylimino)]] tetrakis-benzene-1,3-disulfonic ac
211 ing intracellular pH measurements with 2',7'-bis-(carboxyethyl)-5(6)-carboxyfluorescein (BCECF).
212 allel assays with the pH-sensitive dye 2',7'-bis-(carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF)
213 +) using the H(+)-sensitive dye BCECF [2',7'-bis-(carboxyethyl)-5-(and-6)-carboxyfluorescein] in wide
214   The IL-COOH was further modified with N,N'-bis (carboxymethyl)-l-lysine hydrate to bind copper ions
215          The fluorescent probe rhodamine 110 bis-(CBZ-L-isoleucyl-L-prolyl-L-arginine amide) dihydroc
216 ethylhexyl) adipate (DEHA)), and one FR (2,2-bis (chloromethyl)-propane-1,3-diyltetrakis(2-chloroethy
217                 A novel acetylenic tricyclic bis-(cyano enone), TBE-31, is a lead compound in a serie
218 BF4] (1-3, X = I, Br, and Cl; (t)BuPNP = 2,6-bis-(di-tert-butylphosphinomethyl)pyridine) with coordin
219                                          1,5-Bis-(dihexyl-N-nitrosoamino)-2,4-dinitrobenzene (C6') an
220 ') and an inactive form of the compound [1,5-bis-(dihexylamino)-2,4-dinitrobenzene (C6)] were tested
221 ydrocaffeoyl) spermine (0.2-1.7), N(1),N(10)-bis-(dihydrocaffeoyl) spermidine (1.1-2.6), and N(1),N(5
222 -2.5), sinapoyl hexose (0.1-1.8), N(1),N(14)-bis-(dihydrocaffeoyl) spermine (0.2-1.7), N(1),N(10)-bis
223                                     (99m)Tc-[bis (dimethoxypropylphosphinoethyl)-ethoxyethylamine (PN
224 divergent agents gallamine and hexamethylene-bis-[dimethyl-(3-phthalimidopropyl)ammonium]dibromide (W
225 (30) (dppm)(10) Cl(10) ](4+) (SD/Ag78a; dppm=bis-(diphenylphosphino)methane) that was synthesized thr
226 xy)phenyl]vinyl}-anthracene (A-P6d, 3), 9,10-bis-[(E)-(p-{(E)-[m,p-bis(hexyloxy)phenyl]vinyl}phenyl)v
227 e (BTZT-P6t, 7), and two arylvinylenes, 9,10-bis-{(E)-[m,p-bis(hexyloxy)phenyl]vinyl}-anthracene (A-P
228 or two DEB-specific DNA-DNA cross-links, 1,4-bis-(guan-7-yl)-2,3-butanediol (bis-N7G-BD) and 1-(guan-
229 guanine monoadducts, which can then form 1,4-bis-(guan-7-yl)-2,3-butanediol (bis-N7G-BD) lesions.
230 ify DEB-induced DNA-DNA conjugates, e.g. 1,4-bis-(guan-7-yl)-2,3-butanediol (bis-N7G-BD), 1-(guan-7-y
231 yl-fluoroornitithine) and MGBG [methylgloxal-bis (guanyl hydrazone)].
232 lyamine biosynthesis inhibitor methylglyoxal bis-(guanylhydrazone) (MGBG), but the molecular defects
233 ependence of the UV-vis spectrum of the cis-(bis-(imidazole))ruthenium(III) unit.
234 tention of configuration, of conversion of a bis- into a monoadduct, and of opening of a monoadduct a
235                             Deep anesthesia (BIS &lt; 45) during the intraoperative period is associated
236 sonable binding modes of 2'-MANT-3'-dATP and bis-(M)ANT-nucleotides at sGC alpha1beta1 require a 3'-e
237 }phenyl)ethynyl]-anthracene (PA-P6t, 2), 4,7-bis-{[m,p-bis(hexyloxy)phenyl]ethynyl}-2,1,3-benzothiadi
238 series of five extended arylacetylenes, 9,10-bis-{[m,p-bis(hexyloxy)phenyl]ethynyl}-anthracene (A-P6t
239 reparation of epidithio-, epitetrathio-, and bis-(methylthio)diketopiperazines from diketopiperazines
240 ed bipyridyl ligand is oxidized to mono- and bis- N-oxide species under the reaction conditions, the
241 her than those observed for (64)Cu-di-acetyl-bis (N(4)-methylthiosemicarbazone) and approach those of
242 er medications, acamprosate (Campral-calcium-bis (N-acetylhomotaurinate)) is clinically used in many
243 pylphosphinoethyl)-ethoxyethylamine (PNP5)]-[bis (N-ethoxyethyl)-dithiocarbamato (DBODC)] nitride (N-
244                                          All bis-(N,N-dialkylanilino) donor-substituted push-pull tri
245 e chelating bis-N-heterocyclic carbene (NHC) bis-(N-Dipp-imidazole-2-ylidene)methylene (abbreviated {
246        Complete spectral assignments for the bis-(N-MeIm) and -(4-NMe(2)Py) complexes have been made
247 evious work has shown that certain steroidal bis-(N-phenyl)ureas, derived from cholic acid, form crys
248 nd chelation of intracellular calcium by 1,2-bis (o-Aminophenoxy) ethane-N,N,N',N'-tetraacetic acid t
249  including 2-amino-ethoxydiphenylborate, 1,2-bis (o-aminophenoxy) ethane-tretraacetic acid (acetoxyme
250 psigargin when clamping [Ca(2+)](i) with 1,2-bis (o-Aminophenoxy)ethane-N,N,N',N'tetraacetic acid tet
251 TPEN), a specific zinc chelator, but not 1,2-bis-(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid (
252 rsed with the cell-permeable Ca(2+) chelator bis-(O-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid t
253  with GABA in the absence or presence of 1,2-bis-(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid,
254 ition or by preloading the cells with BAPTA (bis-(o-aminophenoxy)-N,N'N'-tetraacetic acid).
255                          Furthermore, BAPTA [bis-(o-aminophenoxy)ethane-N,N',N'-tetraacetic acid], a
256 s metabolism of NAADP by chelating Ca2+ with bis-(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (B
257 ibited by the calcium chelator 5,5'-dimethyl-bis-(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (d
258 n pyridine leads to the isolation of [Co(I)2(bis-(OMe)salophen)Na2Py4][Na(cryptand)]2, 8.
259           A family of p-cyclophanes based on bis- or tetrafunctionalized 1,4-bisthiophenol units link
260 eaction intermediate, 2 Schiff bases, and 28 bis- or tris(pyrazol-3(4)-yl)methane ligands.
261 of Mfp-2 and iron, which interact by forming bis- or tris-DOPA-iron complexes.
262 eptanone at ca. -23 degrees C to give mono-, bis-, or tris-diazeniumdiolate (-N2O2(-)) products: pota
263 We quantitatively establish the advantage of bis- over mono-intercalators before demonstrating the ap
264   S100beta improved discriminations based on BIS (p = 0.0008), and BIS improved discriminations based
265 lorinated biphenyl (PCB)-153; 1-dichloro-2,2-bis (p-chlorophenyl) ethylene (p,p'-DDE), and hexachloro
266          gstD1 encodes a 1,1,1-trichloro-2,2-bis-(P-chlorophenyl)ethane dehydrochlorinase; gstD21, a
267 detected elevated levels of 1,1-dichloro-2,2-bis-(p-chorophenyl)ethylene and organophosphate metaboli
268              Pretreatment of cp70 cells with bis-(p-nitrophenyl) phosphate, an esterase inhibitor, be
269                                            A bis-(p-nitrophenyl)ureidodecalin shows especially promis
270 )phenyl]ethynyl}-anthracene (A-P6t, 1), 9,10-bis-[(p-{[m,p-bis(hexyloxy) phenyl]ethynyl}phenyl)ethyny
271 (2S)-N-(Boc)-N'-(Phenylsulfonyl)-, (2S)-N,N'-bis-(phenylsulfonyl)-, and (2S)-N,N'-bis-(Boc)-3-(2-pyrr
272 nitude difference in photoreactivity between bis- (photo-DIBOD, 1) and mono-cyclopropenone-caged dibe
273 ed lysis but did not reduce lysis induced by bis (pivaloyloxymethyl) (E)-4-hydroxy-3-methyl-but-2-eny
274 MBPP) or a synthetic cell-permeable prodrug, bis (pivaloyloxymethyl) (E)-4-hydroxy-3-methyl-but-2-eny
275 nzyloxy-imino)-methyl]-1,1'-propane-1,3-diyl-bis -pyridinium dibromide (Duo3), which, in contrast to
276 enzoic acid, and QZ2, 2-[6-hydroxy-3-oxo-4,5-bis-(quinolin-8-ylaminomethyl)-3H-xanthen-9-yl]benz oic
277 idazolium cation, and pKa = 21.2 for the 1,3-bis-((S)-1-phenylethyl)benzimidazolium cation.
278  in the presence of Zn (II)-N,N'-o-phenylene bis (salicylideneimine) ternary complex wherein Zn (II)
279 l behavior in the ground state of [Tb(NP(1,2-bis-(t)Bu-diamidoethane)(NEt(2)))(4)] (measured by Tb L(
280 nate tetravalent terbium complex, [Tb(NP(1,2-bis-(t)Bu-diamidoethane)(NEt(2)))(4)] (where Et is ethyl
281 indicate a 4f(7) ground state for [Tb(NP(1,2-bis-(t)Bu-diamidoethane)(NEt(2)))(4)] with considerable
282 nt, terbium precursor, [(Et(2)O)K][Tb(NP(1,2-bis-(t)Bu-diamidoethane)(NEt(2)))(4)].
283 7,13-diylbis(5-methoxy-6,12-benzof urandiyl)]bis-, tetrakis[(acetyloxy)methyl] ester-detected [Na(+)]
284         The approach is concise and, for the bis-(THF) pair, capitalizes on the full retention of con
285             Poly[{2,5-bis-(2-ethylhexyl)-3,6-bis-(thien-2-yl)-pyrrolo[3,4-c]pyrrole-1,4-diyl} -co-{2,
286                                 In addition, bis-, tri-, and up to octaadducts of Sc3N@C80 were detec
287                                              Bis-[tri-(3,5-di-tert-butyl)phenylmethyl]-peroxide 2 was
288     Small amounts of trans-1,2-cyclohexadiyl bis-(trifluoroacetate) also form.
289   The freed 5-ClUra is derivatized with 3, 5-bis-(trifluoromethyl)-benzyl bromide, which is detected
290 cid (PSA), and benzoic acid (BA) using N-3,5-bis-(trifluoromethyl)-phenyl-N-4-vinylphenyl urea (1) as
291 cting bacteriopurpurin methyl ester with 3,5-bis-(trifluoromethyl)benzylamine, produced promising pho
292                                          3,5-Bis-(trifluoromethyl)phenyl isothiocyanate, was used as
293                                              Bis (trifluoromethylsulfonyl)imide (NTf2) anion of ionic
294 ionic liquid (IL)1-buthyl-methylpyrolydinium bis (trifluromethyl sulfonyl) imide [C(4)mpyr][NTf(2)].
295 -5 pentacene), and 2,2,10,10-tetraethyl-6,14-bis-(triisopropylsilylethynyl)-1,3,9,11-tetraoxa-dicycl
296 ilylethynyl)pentacene (TIPS pentacene), 6,14-bis-(triisopropylsilylethynyl)-1,3,9,11-tetraoxa-dicyclo
297 h the use of the bridged polysilsesquioxane, bis-(trimethoxysilylethyl)benzene (BTEB), as the princip
298  QSAR investigations of a series of 53 novel bis-, tris-, and tetrakis(carboxylato)platinum(IV) compl
299                           A series of mono-, bis-, tris-, and tetrakis(porphinato)zinc(II) (PZn)-elab
300                                              Bis-, tris-, and tetrakisuracil-substituted 12-, 13-, 17

 
Page Top